Lymphadenopathy (1:30), galantamine for dementia (5:30), parenteral agents for migraines (7:30), EpiSwitch prostate cancer screening test (10:40), vitamin B12 deficiency (14:00), and fezolinetant for menopause (17:40).

Respiratory syncytial virus vaccination in pregnancy (1:30), vasectomy (3:40), donanemab in Alzheimer disease (7:20), multicancer early detection (12:20), autism spectrum disorder (13:50), and acute pancreatitis (17:10).

Contraception (1:30), delayed pushing in labor (6:10), bacterial vaginosis (8:50), outpatient care of the premature infant (11:10), nocturnal leg cramps (17:30), and AFP Clinical Answers (19:20).

Heart failure with reduced ejection fraction (1:30), lower gastrointestinal bleeding (5:10), venous leg ulcers (7:10), nonopioid pharmacologic management of chronic pain (10:30), resuscitation in burns (15:20), and breast ductal carcinoma in situ (17:10).

Intimate partner violence (1:40), top 20 research studies of 2024 for primary care physicians (5:20), treatments for carpal tunnel syndrome (11:20), benzgalantamine for Alzheimer disease (13:50), bright light therapy (17:50), assessment and management of patients at risk for suicide (20:10).

Foreign bodies in the ear, nose, and throat (1:30); topical anti-inflammatory drugs for eczema (7:20); intravenous antihypertensives (10:10); developmental screening (14:00); dialectical behavior therapy (17:10); and universal respiratory syncytial virus prophylaxis (20:10).

Nocturia (1:30), assessing the risk of atrial fibrillation (5:00), zoledronate reduces fracture risk (7:20), endometrial cancer (10:10), diabetes-related foot infections (13:50), and at-home gonorrhea and chlamydia testing (15:50).

Acute monoarthritis (1:30), improving adverse drug reaction reporting (6:30), inappropriate use of oral antiplatelet drugs (9:50), long-term opioid therapy (12:40), treating Clostridioides difficile infection (17:10), and lecanemab for Alzheimer disease (19:00).

Migraine headache prophylaxis (1:30), atrial fibrillation with stable coronary artery disease (6:10), health maintenance in postmenopausal women (8:50), topical testosterone (13:50), pain control in primary dysmenorrhea (17:50), and obstructive sleep apnea in children (20:00).

Trigeminal neuralgia (1:30), early medication abortion (4:30), sodium-glucose cotransporter-2 inhibitors (6:00), female sexual dysfunction (8:40), per- and polyfluoroalkyl substances (12:30), and methotrexate for juvenile idiopathic arthritis (17:20).